X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (117) 117
hematology (93) 93
index medicus (71) 71
male (58) 58
oncology (54) 54
female (51) 51
adult (46) 46
middle aged (46) 46
aged (40) 40
imatinib mesylate (32) 32
chronic myelogenous leukemia (30) 30
benzamides (27) 27
hemic and lymphatic diseases (26) 26
leukemia, myelogenous, chronic, bcr-abl positive - genetics (26) 26
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (25) 25
adolescent (24) 24
antineoplastic agents - therapeutic use (24) 24
bcr-abl (24) 24
prognosis (24) 24
treatment outcome (24) 24
imatinib (23) 23
hematology, oncology and palliative medicine (21) 21
pyrimidines - therapeutic use (21) 21
chronic myeloid-leukemia (19) 19
leukemia (19) 19
mutation (19) 19
piperazines - therapeutic use (19) 19
expression (18) 18
fusion proteins, bcr-abl - genetics (18) 18
research (17) 17
chronic myeloid leukemia (15) 15
precursor cell lymphoblastic leukemia-lymphoma - genetics (15) 15
animals (14) 14
genetic aspects (14) 14
leukemia, myeloid, acute - genetics (14) 14
protein kinase inhibitors - therapeutic use (14) 14
acute myeloid-leukemia (13) 13
cancer (13) 13
therapy (13) 13
health aspects (12) 12
minimal residual disease (12) 12
philadelphia-chromosome (12) 12
resistance (12) 12
survival (12) 12
wt1 proteins - genetics (12) 12
acute lymphoblastic-leukemia (11) 11
aged, 80 and over (11) 11
care and treatment (11) 11
cell biology (11) 11
cml (11) 11
gene expression (11) 11
mutations (11) 11
myelodysplastic syndromes (11) 11
philadelphia chromosome (11) 11
polymerase-chain-reaction (11) 11
remission induction (11) 11
reverse transcriptase polymerase chain reaction (11) 11
wt1 (11) 11
bone marrow (10) 10
drug resistance, neoplasm (10) 10
tyrosine kinase (10) 10
young adult (10) 10
acute leukemia (9) 9
anemia (9) 9
cells (9) 9
chronic-phase (9) 9
disease-free survival (9) 9
fusion proteins, bcr-abl - antagonists & inhibitors (9) 9
myeloproliferative neoplasms (9) 9
piperazines - administration & dosage (9) 9
protein-tyrosine kinases - antagonists & inhibitors (9) 9
pyrimidines - administration & dosage (9) 9
risk factors (9) 9
acute myeloid leukemia (8) 8
analysis (8) 8
apoptosis (8) 8
clinical trials as topic (8) 8
dasatinib (8) 8
disease progression (8) 8
drug resistance, neoplasm - genetics (8) 8
flow cytometry (8) 8
gene (8) 8
gene expression regulation, leukemic (8) 8
gene expression regulation, neoplastic (8) 8
gene mutations (8) 8
minimal-residual-disease (8) 8
original (8) 8
original article (8) 8
polymerase chain reaction (8) 8
remission (8) 8
transplantation (8) 8
abl tyrosine kinase (7) 7
blast crisis (7) 7
clinical resistance (7) 7
hematopoietic stem cells (7) 7
interferon-alpha (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (7) 7
leukemia, myeloid, acute - diagnosis (7) 7
mesylate (7) 7
mice (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 3, pp. 219 - 228
Journal Article
Haematologica, ISSN 0390-6078, 02/2013, Volume 98, Issue 2, pp. 193 - 200
Imatinib has so far been the first-choice treatment in chronic myeloid leukemia with excellent results. However, only a proportion of patients achieve major... 
CHRONIC MYELOGENOUS LEUKEMIA | CHRONIC-PHASE | LOW OCT-1 ACTIVITY | STANDARD-DOSE IMATINIB | TYROSINE KINASE INHIBITOR | MDR1 GENE | FOLLOW-UP | DRUG-RESISTANCE | HEMATOLOGY | MULTIDRUG-RESISTANCE GENE | CML PATIENTS | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Benzamides - metabolism | Cytochrome P-450 Enzyme System - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Piperazines - metabolism | Antineoplastic Agents - therapeutic use | Pyrimidines - metabolism | Antineoplastic Agents - metabolism | Young Adult | Benzamides - therapeutic use | Cytochrome P-450 CYP3A - genetics | Cation Transport Proteins - metabolism | Adult | Cation Transport Proteins - genetics | Female | Organic Cation Transport Proteins - metabolism | Genotype | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Cytochrome P-450 CYP3A - metabolism | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Alleles | Cytochrome P-450 Enzyme System - genetics | Aged | Polymorphism, Single Nucleotide | Organic Cation Transport Proteins - genetics | Protein Kinase Inhibitors - metabolism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2005, Volume 353, Issue 10, pp. 977 - 987
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 22 - 33
Journal Article
Haematologica, ISSN 0390-6078, 06/2012, Volume 97, Issue 6, pp. 907 - 914
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2005, Volume 23, Issue 18, pp. 4100 - 4109
Journal Article
Cell Death and Disease, ISSN 2041-4889, 2017, Volume 8, Issue 6, pp. e2849 - e2849
Lin28A is a highly conserved RNA-binding protein that concurs to control the balance between stemness and differentiation in several tissue lineages. Here, we... 
RNA-BINDING PROTEINS | MESSENGER-RNAS | SIGNATURES | ACUTE LYMPHOBLASTIC-LEUKEMIA | HEMATOPOIETIC STEM-CELLS | GENE-EXPRESSION | CLASSIFICATION | REGULATORS | MICRORNA EXPRESSION | CANCER | CELL BIOLOGY | RNA-Binding Proteins - genetics | Annexin A1 - genetics | Antigens, CD34 - metabolism | MicroRNAs - antagonists & inhibitors | Early Growth Response Protein 2 - genetics | Humans | Leukemia, Myeloid, Acute - metabolism | MicroRNAs - metabolism | Lentivirus - metabolism | Tristetraprolin - metabolism | Cell Cycle Checkpoints - genetics | Lentivirus - genetics | Cell Differentiation | Myeloid Progenitor Cells - metabolism | Genetic Vectors - chemistry | Signal Transduction | Leukemia, Myeloid, Acute - pathology | Genetic Vectors - metabolism | Hematopoiesis - genetics | Myeloid Progenitor Cells - pathology | Gene Expression Regulation, Leukemic | Tristetraprolin - genetics | Cell Line, Tumor | Annexin A1 - metabolism | Early Growth Response Protein 2 - metabolism | MicroRNAs - genetics | Primary Cell Culture | Antagomirs - metabolism | Antagomirs - genetics | Antigens, CD34 - genetics | RNA-Binding Proteins - metabolism | Leukemia, Myeloid, Acute - genetics | CD34 antigen | Cell proliferation | Myeloid leukemia | Leukemia | Blast | Macrophages | Ribonucleic acid--RNA | Promyeloid leukemia | RNA-binding protein | Transfection | MicroRNAs | Classification | Cell lines | Stem cells | Cell cycle | Protein expression | Egr-2 protein | Acute myeloid leukemia | Blast cells | Acute promyeloid leukemia | Original
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 10, pp. 2159 - 2167
Journal Article